Floatz logo

cd30.car-t

Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Tessa TherapeuticsCell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

86 Active assets in the Primary Mediastinal Large B-Cell Lymphoma (PMBCL) cohort.

Asset / SponsorPhaseRating
Ifosfamide
David Bond, MD
Phase 4BBB
Inno-206
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
Inno-206
University of Washington
Phase 4BBB

View all 50 →

Same molecule, other indications

cd30.car-t is also rated in:

Hodgkins lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
anaplastic large cell lymphomaDormant
CC
Indicative ·
41 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →